Browsing Category

Supplier News

112 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Test: FDA Scorecard: Drug Shortages and Inspections
By

By
How has the FDA performed in mitigating drug shortages and in its inspection activity since the COVID-19 pandemic? Has it been able to keep drug shortages down and keep pace with its inspection activity on levels on par pre-pandemic? Two recent reports tell the story.

Test: Pfizer To Acquire Biohaven Pharmaceuticals for $11.6 Bn
By

By
Pfizer has agreed to acquire Biohaven Pharmaceuticals, a bio/pharmaceutical company with lead assets for treating migraines, for approximately $11.6 billion. The pending acquisition follows the completion of a $1.24-billion licensing…

DCAT Week 2022: Supplier News Roundup: Formulation Development, Drug-Product Mfg & Packaging
By

By
As part of the DCAT Member Company Announcement Forum, held on March 21, 2022, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT), DCAT…

DCAT Week 2022: Supplier News Roundup: Chemicals & Chemical API Mfg
By

By
As part of the DCAT Member Company Announcement Forum, held on March 21, 2022, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT), DCAT…

News from DCAT Week 2022: IDT Biologika Announcing $100-M-Plus Expansion Plan
By

By
IDT Biologika is investing more than EUR 100 million ($110 million) to expand drug-substance and drug- product manufacturing, visual inspection, and packaging capacities. Dr. Anne Bouchet, Senior Manager, IDT Biologika,…

News from DCAT Week 2022: Selkirk Pharma Expanding Injectables Mfg
By

By
Selkirk Pharma, a Spokane, Washington-based CDMO of injectable drugs, announced plans to expand manufacturing capacity by adding two additional production lines at its facility in Spokane. Selkirk specializes in the…

News from DCAT Week 2022: HAS Healthcare Advanced Synthesis Outlines Multi-Year Expansion Plan
By

By
HAS Healthcare Advanced Synthesis (formerly Helsinn Advanced Synthesis), which launched as an independent business earlier this year (2022), is proceeding with a multi-year CHF 100-million-plus ($108-million) investment plan to expand…

News from DCAT Week 2022: AGC Biologics CEO Outlines $1.6-Bn Expansion Plan
By

By
Patricio Massera, CEO, AGC Biologics, a biologics CDMO, outlined a $1.6-billion expansion plan over the next four years in its global biomanufacturing network at the DCAT Member Company Announcement Forum…

News from DCAT Week 2022: CordenPharma Acquires Three Drug-Product Mfg Facilities
By

By
CordenPharma has added to its drug-product manufacturing with the acquisition of three facilities from Vifor Pharma, a Saint Gallen, Switzerland-headquartered specialty pharmaceutical company. Dr. Stephen Houldsworth, Vice President, Global Head…

News from DCAT Week 2022: Lonza Highlights Major Biomanufacturing Expansions
By

By
Lonza is proceeding with major expansions in its global biomanufacturing manufacturing network as wel as with targeted investment in parenteral drug-product manufacturing. Jean-Christophe Hyvert, President of Lonza’s Biologics and Cell…